trending Market Intelligence /marketintelligence/en/news-insights/trending/Ng5CblpgNCJlbGtr2a_6Ag2 content esgSubNav
In This List

GSK exec joins Novelion Therapeutics as EVP/head of R&D

Blog

Post-webinar Q&A: Global Credit Risk Trends 2021 and Beyond

Blog

University Essentials: From Crisis to Resilience – Navigating Sustainable Recovery

Blog

EV impact; vaccines to boost job market; coal supply constraints

Blog

Shore Capital is Now Available in S&P Global’s Aftermarket Research Collection


GSK exec joins Novelion Therapeutics as EVP/head of R&D

Murray Stewart will become Novelion Therapeutics Inc.'s executive vice president and head of research and development Nov. 27.

Stewart is joining Novelion Therapeutics from GlaxoSmithKline plc, where he serves as the chief medical officer.